AQB
NASDAQ
US
AquaBounty Technologies, Inc. - Common Stock
$0.88
▼ $-0.01
(-1.02%)
Vol 10K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.6M
ROE
-600.8%
Margin
-5866.1%
D/E
64.63
Beta
1.25
52W
$0–$3
Wall Street Consensus
8 analysts · Apr 20250
Strong Buy
0
Buy
3
Hold
4
Sell
1
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Sep 2024 | $-0.89 | $-0.88 | +$0.01 |
| Jun 2024 | $-1.16 | $-1.57 | $-0.41 |
| Mar 2024 | $-1.54 | $-2.90 | $-1.36 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | -$705K | — | — | — |
| Net Income | -$3.4M | -$84.1M | $401K | -$3.4M | -$1.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -246.6% | -233.4% | -233.4% | -233.4% | -600.8% | -600.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -5827.8% | -5827.8% | -5827.8% | -5866.1% | -5866.1% |
| Gross Margin | — | -724.6% | -724.6% | -724.6% | -724.6% | -724.6% |
| D/E Ratio | 62.48 | 62.48 | 62.48 | 62.48 | 64.63 | 64.63 |
| Current Ratio | 0.30 | 0.30 | 0.30 | 0.30 | 0.12 | 0.12 |
Key Ratios
ROA (TTM)
-309.3%
P/S (TTM)
2.87
P/B
0.2
EPS (TTM)
$-22.83
CF/Share
$-6.29
Rev Growth 3Y
+166.9%
52W High
$2.95
52W Low
$0.50
$0.50
52-Week Range
$2.95
Financial Health
Free Cash Flow
-$1.7M
Net Debt
$7.0M
Cash
$951K
Total Debt
$7.9M
As of Sep 30, 2025
How does AQB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
AQB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.9
▼
78%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.2
▼
94%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
AQB profitability vs Biotechnology peers
ROE
-600.8%
▼
793%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-5866.1%
▼
1946%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
-724.6%
▼
1022%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-309.3%
▼
562%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
AQB financial health vs Biotechnology peers
D/E ratio
64.6
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.1
▼
97%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.3
▲
29%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
AQB fundamentals radar
AQB
Peer median
Industry
AQB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
AQB vs peers: key metrics
Top Holders
Top 5: 9.45%Renaissance Technologies, L…
3.14%
$108K
EPIQ Partners, LLC
2.30%
$79K
Two Sigma Investments, LP
1.80%
$62K
Blackrock Inc.
1.23%
$42K
Two Sigma Advisers, LP
0.98%
$34K
As of Dec 31, 2025
Latest News
No related news yet